Optimizing treatment for older adults with depression

Keyphrases

• Older Adults 100%
• Antidepressants 100%
• Treatment Optimization 100%
• Benzodiazepines 66%
• Selective Serotonin Reuptake Inhibitors 66%
• Medicines Optimisation 66%
• Remission 33%
• Therapeutic Implications 33%
• Counseling 33%
• Insomnia 33%
• Treatment-resistant Depression 33%
• Medication Management 33%
• Recurrent Episodes 33%
• Psychosis 33%
• Outpatient Setting 33%
• Allergy 33%
• Late-life Depression 33%
• Dose-ranging 33%
• Augmentation Strategy 33%
• Aripiprazole 33%
• Cognitive Effects 33%
• Muscle Spasm 33%
• Bupropion 33%
• Optimal Dose 33%
• Serotonin-norepinephrine Reuptake Inhibitors 33%
• Mirtazapine 33%
• Appropriate Medication 33%
• Inappropriate Medication 33%
• Bladder Spasm 33%
• Measurement-based Care 33%
• Concurrent Use 33%
• Treatment Lines 33%
• Overactive Bladder 33%
• Depression Remission 33%
• Anticholinergic Medications 33%
• Managing Anxiety 33%

Medicine and Dentistry

• Antidepressant 100%
• Parasympatholytic 66%
• Benzodiazepine Derivative 66%
• Outpatient 33%
• Counseling 33%
• Overactive Bladder 33%
• Optimal Drug Dose 33%
• Treatment Resistant Depression 33%
• Selective Serotonin Reuptake Inhibitor 33%
• Aripiprazole 33%
• Late Life Depression 33%
• Muscle Spasm 33%
• Bupropion 33%
• Mirtazapine 33%
• Serotonin-Norepinephrine Reuptake Inhibitor 33%
• Bladder Spasm 33%
• Side Effect 33%
• Psychosis 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antidepressant 100%
• Remission 66%
• Cholinergic Receptor Blocking Agent 66%
• Treatment Resistant Depression 33%
• Late Life Depression 33%
• Muscle Spasm 33%
• Selective Serotonin Reuptake Inhibitor 33%
• Aripiprazole 33%
• Overactive Bladder 33%
• Bupropion 33%
• Mirtazapine 33%
• Serotonin-Norepinephrine Reuptake Inhibitor 33%
• Bladder Spasm 33%
• Side Effect 33%
• Psychosis 33%